Catherine M. Szyman

CIK 1438538 · Chief Executive Officer · last filed 2026-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.52M

Companies

5

Total Filings

116

Lifetime Open-Market Net

-$46.57M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MASI CEO 8,674 $179.95 $1.56M $0 5 2026-03-16
Inari Medical, Inc. (NARI) Delisted Director 0 $79.97 $0 $533.7K 8 2025-02-19
EW CVP, Critical Care 81,287 $85.11 $6.92M -$42.15M 88 2024-09-03
OM Director 24,596 $4.49 $110.4K $0 4 2023-05-31
MDT SrVP & Pres Diabetes 36,521 $80.20 $2.93M -$4.95M 10 2014-03-21

Recent Filings · Page 12 of 12

116 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2009-08-05 MDT Grant (A) +6,960 $0 EDGAR
2009-05-27 MDT Sell (S) −3,868 -$124.4K EDGAR
2009-04-02 MDT Tax (F) −1,297 -$38.2K EDGAR
2008-10-29 MDT Grant (A) +5,519 $0 EDGAR
2008-07-30 MDT Grant (A) +18,918 $0 EDGAR
2008-07-14 MDT Mixed -$160.2K EDGAR
Showing 111116 of 116
Page 12 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.